Cryptosporidiosis should be designated as a tropical disease by the US Food and Drug Administration.
PLoS Negl Trop Dis.
2020 Jul;14(7):e0008252. doi: 10.1371/journal.pntd.0008252. eCollection 2020 Jul. PubMed PMID:
32614819; PubMed Central PMCID:
PMC7332027.
HBV replication inhibitors.
Antiviral Res.
2020 Jul;179:104815. doi: 10.1016/j.antiviral.2020.104815. Epub 2020 May 5. Review. PubMed PMID:
32380149; PubMed Central PMCID:
PMC7293572.
The CRYPTOFAZ trial and lessons learned for anticryptosporidial drug development.
Clin Infect Dis.
2020 Apr 11;. doi: 10.1093/cid/ciaa425. [Epub ahead of print] PubMed PMID:
32277815.
Identification of 4-Amino-Thieno[2,3-d]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis.
mSphere.
2019 Sep 11;4(5). doi: 10.1128/mSphere.00606-19. PubMed PMID:
31511370; PubMed Central PMCID:
PMC6739496.
Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.
J Pharmacol Exp Ther.
2019 Aug;370(2):219-230. doi: 10.1124/jpet.119.259663. Epub 2019 Jun 12. PubMed PMID:
31189728; PubMed Central PMCID:
PMC6652132.
Phosphonate prodrugs: an overview and recent advances.
Future Med Chem.
2019 Jul;11(13):1625-1643. doi: 10.4155/fmc-2018-0591. Review. PubMed PMID:
31469328; PubMed Central PMCID:
PMC6722485.
4-Aryl Pyrrolidines as Novel Orally Efficacious Antimalarial Agents. Part 2: 2-Aryl-N-(4-arylpyrrolidin-3-yl)acetamides.
ACS Med Chem Lett.
2019 Jun 13;10(6):966-971. doi: 10.1021/acsmedchemlett.9b00123. eCollection 2019 Jun 13. PubMed PMID:
31223456; PubMed Central PMCID:
PMC6580545.
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.
J Clin Invest.
2019 May 14;129(7):2745-2759. doi: 10.1172/JCI124738. PubMed PMID:
31085833; PubMed Central PMCID:
PMC6597242.
Chemical Approaches to Inhibiting the Hepatitis B Virus Ribonuclease H.
ACS Infect Dis.
2019 May 10;5(5):655-658. doi: 10.1021/acsinfecdis.8b00045. Epub 2018 Mar 22. Review. PubMed PMID:
29565562; PubMed Central PMCID:
PMC7202671.
4-Aryl Pyrrolidines as a Novel Class of Orally Efficacious Antimalarial Agents. Part 1: Evaluation of 4-Aryl- N-benzylpyrrolidine-3-carboxamides.
J Med Chem.
2019 Apr 11;62(7):3503-3512. doi: 10.1021/acs.jmedchem.8b01972. Epub 2019 Mar 22. PubMed PMID:
30856324; PubMed Central PMCID:
PMC6727846.
Endonuclease Activity Inhibition of the NS1 Protein of Parvovirus B19 as a Novel Target for Antiviral Drug Development.
Antimicrob Agents Chemother.
2019 Mar;63(3). doi: 10.1128/AAC.01879-18. Print 2019 Mar. PubMed PMID:
30530599; PubMed Central PMCID:
PMC6395930.
Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.
J Med Chem.
2018 Dec 13;61(23):10415-10439. doi: 10.1021/acs.jmedchem.8b00392. Epub 2018 Sep 9. PubMed PMID:
30130103.
Synthesis and Evaluation of Troponoids as a New Class of Antibiotics.
ACS Omega.
2018 Nov 30;3(11):15125-15133. doi: 10.1021/acsomega.8b01754. Epub 2018 Nov 8. PubMed PMID:
30533576; PubMed Central PMCID:
PMC6275967.
MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.
J Med Chem.
2018 Oct 11;61(19):8847-8858. doi: 10.1021/acs.jmedchem.8b01026. Epub 2018 Sep 24. PubMed PMID:
30192536; PubMed Central PMCID:
PMC6300130.
Antifungal Phenothiazines: Optimization, Characterization of Mechanism, and Modulation of Neuroreceptor Activity.
ACS Infect Dis.
2018 Apr 13;4(4):499-507. doi: 10.1021/acsinfecdis.7b00157. Epub 2017 Nov 2. PubMed PMID:
29058407.
A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
Antimicrob Agents Chemother.
2018 Apr;62(4). doi: 10.1128/AAC.01505-17. Print 2018 Apr. PubMed PMID:
29339392; PubMed Central PMCID:
PMC5913971.
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model.
PLoS Negl Trop Dis.
2018 Jan;12(1):e0006183. doi: 10.1371/journal.pntd.0006183. eCollection 2018 Jan. PubMed PMID:
29309415; PubMed Central PMCID:
PMC5774826.
Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion.
Science.
2017 Oct 27;358(6362):518-522. doi: 10.1126/science.aan1478. PubMed PMID:
29074774; PubMed Central PMCID:
PMC5928414.
The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
PLoS One.
2017;12(10):e0185906. doi: 10.1371/journal.pone.0185906. eCollection 2017. PubMed PMID:
28973041; PubMed Central PMCID:
PMC5626496.
Rev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistrome.
Mol Metab.
2017 Jul;6(7):703-714. doi: 10.1016/j.molmet.2017.05.001. eCollection 2017 Jul. PubMed PMID:
28702326; PubMed Central PMCID:
PMC5485243.
Troponoids Can Inhibit Growth of the Human Fungal Pathogen Cryptococcus neoformans.
Antimicrob Agents Chemother.
2017 Apr;61(4). doi: 10.1128/AAC.02574-16. Print 2017 Apr. PubMed PMID:
28167553; PubMed Central PMCID:
PMC5365692.
Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors.
Antiviral Res.
2016 Nov;135:24-30. doi: 10.1016/j.antiviral.2016.09.009. Epub 2016 Sep 28. PubMed PMID:
27693161; PubMed Central PMCID:
PMC5099120.
Synthesis, antimalarial properties and 2D-QSAR studies of novel triazole-quinine conjugates.
Bioorg Med Chem.
2016 Aug 15;24(16):3527-39. doi: 10.1016/j.bmc.2016.05.060. Epub 2016 May 30. Review. PubMed PMID:
27298002.
Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea.
J Pharmacol Exp Ther.
2016 May;357(2):423-31. doi: 10.1124/jpet.115.231167. Epub 2016 Feb 23. PubMed PMID:
26907621; PubMed Central PMCID:
PMC4851326.
Characterization of the C-Terminal Nuclease Domain of Herpes Simplex Virus pUL15 as a Target of Nucleotidyltransferase Inhibitors.
Biochemistry.
2016 Feb 9;55(5):809-19. doi: 10.1021/acs.biochem.5b01254. Epub 2016 Feb 1. PubMed PMID:
26829613; PubMed Central PMCID:
PMC4819167.
Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents.
Bioorg Med Chem.
2015 Aug 15;23(16):5144-50. doi: 10.1016/j.bmc.2015.02.050. Epub 2015 Mar 4. PubMed PMID:
25797165; PubMed Central PMCID:
PMC4550221.
Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity.
Antimicrob Agents Chemother.
2015 Feb;59(2):1070-9. doi: 10.1128/AAC.04617-14. Epub 2014 Dec 1. PubMed PMID:
25451058; PubMed Central PMCID:
PMC4335860.
Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity.
Antiviral Res.
2014 Aug;108:48-55. doi: 10.1016/j.antiviral.2014.05.007. Epub 2014 May 20. PubMed PMID:
24858512; PubMed Central PMCID:
PMC4101055.
Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist.
J Med Chem.
2014 May 22;57(10):4273-88. doi: 10.1021/jm500206r. Epub 2014 Apr 30. PubMed PMID:
24738581.
Evaluation of aminohydantoins as a novel class of antimalarial agents.
ACS Med Chem Lett.
2014 Jan 9;5(1):89-93. doi: 10.1021/ml400412x. eCollection 2014 Jan 9. PubMed PMID:
24900778; PubMed Central PMCID:
PMC4027786.
Synthesis and antimalarial bioassay of quinine - peptide conjugates.
Chem Biol Drug Des.
2013 Oct;82(4):361-6. doi: 10.1111/cbdd.12134. PubMed PMID:
23497252.
The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.
PLoS Pathog.
2013 Jan;9(1):e1003125. doi: 10.1371/journal.ppat.1003125. Epub 2013 Jan 22. PubMed PMID:
23349632; PubMed Central PMCID:
PMC3551811.
Quinine bis-conjugates with quinolone antibiotics and peptides: synthesis and antimalarial bioassay.
Org Biomol Chem.
2012 Dec 7;10(45):8985-93. doi: 10.1039/c2ob26439k. Epub 2012 Oct 16. PubMed PMID:
23070233.
Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts.
Curr Top Med Chem.
2012;12(5):445-55. doi: 10.2174/156802612799362959. Review. PubMed PMID:
22242846.
Editorial: the medicinal chemistry of novel approaches for the treatment of malaria.
Curr Top Med Chem.
2012;12(5):371-2. doi: 10.2174/156802612799362931. PubMed PMID:
22242844.
Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds.
Bioorg Med Chem Lett.
2011 Nov 1;21(21):6538-44. doi: 10.1016/j.bmcl.2011.08.055. Epub 2011 Aug 22. PubMed PMID:
21924614.
Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
Bioorg Med Chem Lett.
2011 Nov 1;21(21):6545-53. doi: 10.1016/j.bmcl.2011.08.048. Epub 2011 Aug 19. PubMed PMID:
21924613.
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy.
J Med Chem.
2010 Aug 26;53(16):5979-6002. doi: 10.1021/jm100505n. PubMed PMID:
20672822.
A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.
J Pharmacol Exp Ther.
2010 Jun;333(3):797-807. doi: 10.1124/jpet.110.166173. Epub 2010 Mar 17. PubMed PMID:
20237073.
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode.
Bioorg Med Chem Lett.
2010 Mar 1;20(5):1543-7. doi: 10.1016/j.bmcl.2010.01.078. Epub 2010 Jan 21. PubMed PMID:
20137931.
Synthesis of tert-butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate.
Org Lett.
2009 Aug 20;11(16):3523-5. doi: 10.1021/ol901325s. PubMed PMID:
19637855.
Benzothiophene inhibitors of MK2. Part 2: improvements in kinase selectivity and cell potency.
Bioorg Med Chem Lett.
2009 Aug 15;19(16):4882-4. doi: 10.1016/j.bmcl.2009.02.017. Epub 2009 Feb 8. PubMed PMID:
19616942.
Benzothiophene inhibitors of MK2. Part 1: structure-activity relationships, assessments of selectivity and cellular potency.
Bioorg Med Chem Lett.
2009 Aug 15;19(16):4878-81. doi: 10.1016/j.bmcl.2009.02.015. Epub 2009 Feb 8. PubMed PMID:
19616945.
Novel tetrahydro-beta-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2).
Bioorg Med Chem Lett.
2007 Aug 15;17(16):4657-63. doi: 10.1016/j.bmcl.2007.05.070. Epub 2007 May 25. PubMed PMID:
17570666.
Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).
J Med Chem.
2007 May 31;50(11):2647-54. doi: 10.1021/jm0611004. Epub 2007 May 5. PubMed PMID:
17480064.
Non-steroidal Mineralocorticoid Receptor Antagonists.
Expert Opin Therapeutic Patents. 2007; 17:17-23.
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
Nat Struct Biol.
2002 May;9(5):359-64. doi: 10.1038/nsb787. PubMed PMID:
11953755.
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
J Med Chem.
2001 Nov 22;44(24):4230-51. doi: 10.1021/jm010254a. PubMed PMID:
11708925.
Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
J Med Chem.
1999 Jul 1;42(13):2456-68. doi: 10.1021/jm990101b. PubMed PMID:
10395487.
Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.
Endocrinology.
1999 Feb;140(2):800-4. doi: 10.1210/endo.140.2.6480. PubMed PMID:
9927308.
What would you like to do?